Japanese Circulation Society

73rd Annual Scientific Meeting Japanese Circulation Society

Date : March 20(Fri) - 22(Sun), 2009

Venues : Osaka International Convention Center RIHGA Royal Hotel Osaka Hotel NCB

Congress Chairperson : Masatsugu Hori (Osaka Medical Center for Cancer and Cardiovascular Diseases)

Presidential Lecture

Presidential Lecture	Cardioprotection from Cardiovascular Risk—From Gene to Population Science
	Masatsugu Hori, MD, Ph.D Osaka Medical Center for Cancer and Cardiovascular Diseases, Japan

Special Lectures

Special Lecture 2	The Global Epidemic of Cardiovascular Disease – Need for a Multidimensional Approach
	Salim Yusuf McMaster University and Hamilton Health Sciences Corporation, Canada

Special Lecture 6	Aging and Cardiovascular Disease: A Medical Challenge
	David T. Kelly University of Sydney, Australia

Special Lecture 7	Controversies in PCI: DES vs CABG for ULMA
	Richard A. Schatz Scripps Clinic, La Jolla, USA.

Special Lecture 8	From the Ryanodine Receptor to Cardiac Arrhythmias
	David Eisner University of Manchester, United Kingdom

Special Lecture 10	Why do we still not have cardioprotective drugs?
	James Downey, PhD Professor of Physiology, University of South Alabama, Mobile, Alabama, USA

Special Lecture 13	Heart Failure: A Cardio-Renal-Vascular Syndrome
	Marvin A. Konstam, MD Tufts Medical Center, USA

Special Lecture 14	The Initiation of the Heart Beat
	Peng-Sheng Chen, MD Krannert Institute of Cardiology, Indiana University School of Medicine, Indiana, USA

Plenary Sessions

Plenary Session 3	New Era of Catheter Ablation for Ventricular Arrhythmias
	David J. Callans, MD University of Pennsylvania School of Medicine, Pennsylvania, USA Akihiko Nogami, MD Yokohama Rosai Hospital, Japan Yukio Sekiguchi Graduate School of Comprehensive Human Sciences, University of Tsukuba, Japan Yoshinori Kobayashi Tokai University, Japan

Plenary Session 4	Pathophysiology and Therapeutic Strategy for Diastolic Dysfunction in Heart Failure.
	Rick Nishimura Mayo Clinic Rochester, USA Hiromitsu Matsui University of Tokyo, Japan Naoki Fujimoto Mie University, Japan Yoshihiro Fukumoto Tohoku University Graduate School of Medicine, Japan

Plenary Session 6	Frontiers in Regeneration with Pluripotent Cells
	Ulrich Martin Hannover Medical School, Germany Shinsuke Yuasa Keio University School of Medicine, Japan

Symposia

Symposium 1	Biomarkers, Genetic Polymorphisms, and Risk Estimation
	Daniel Levy Framingham Heart Study, Boston University School of Medicine, Harvard Medical School, USA Shoji Sanada Brigham & Women's Hospital, Harvard Medical School, USA Takayoshi Tsutamoto Shiga University of Medical Science, Japan

Symposium 2	Current Status and Future Perspective of Antiplatelet Therapy in Management of Coronary Artery Disease
	David J. Moliterno University of Kentucky, USA John H.P. Alexander Duke University Medical Center, USA Shiro Uemura Nara Medical University, Japan Hisanori Horiuchi Kyoto University, Japan Shinya Goto Tokai University, Isehara

Joint Symposia

ACC-JCS Joint Symposium	Optimal Strategy for Cardiac Resynchronization Therapy: Who Can Benefit From CRT?
	Kazutaka Aonuma University of Tsukuba, Japan Satoshi Nakatani Osaka University, Japan Morio Shoda Tokyo Women's University, Japan John F. Beshai University of Chicago, USA

ESC-JCS Joint Symposium	Hypertrophic Cardiomyopathy: New Insights into Clinical Course and Management.
	Albert Hagege Hospital European Georges Pompidou, France Makoto Okawa Ventricular Remodeling, Heart Failure, and End-Stage HCM

APSC-JCS Joint Symposium	Heart Transplantation in Asia-Pacific Region: Its Status and Tasks.
	Donald Esmore Alfred Healthcare Group, Australia Pyo Won Park Samsung Medical Center, Republic of Korea Kazuhiko Nishigaki Gifu University School of Medicine, Japan

KSC-JCS Joint Symposium	Novel Therapeutic Strategies against Heart Failure
	Eun Seok Jeon Samsung Medical Center, Korea Takeshi Yamamoto Yamaguchi University, Japan Tohru Minamino Chiba University, Japa

AHA-JCS Joint Symposium	Strategies for Prevention and Management of Atherosclerotic Diseases
	Daniel Levy Framingham Heart Study, Boston University School of Medicine, Harvard Medical School, USA.